Alpharma Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 5 Calls Today's Calls

Call Details Alpharma Earnings Conference Call (Q1 2008) Mon, May 5, 2008, 8:30 am Eastern Listen to the archived event audio About Alpharma (NYSE:ALO) Alpharma, Inc. develops, manufactures, and markets pharmaceutical products for humans and animals worldwide. The company’s Pharmaceuticals segment markets branded pharmaceutical prescription product, which includes pain medication products sold under the trademark of KADIAN; and a prescription topical non-steroidal anti-inflammatory patch product under the trademark of FLECTOR. This segment develops an investigational abuse deterrent extended-release morphine product, which is in Phase III clinical trials. It also distributes TIROSINT gel capsules for thyroid hormone replacement therapy. Alpharma’s AH segment engages in the development, registration, manufacturing, and marketing of medicated feed additives and water soluble therapeutics for poultry, cattle, and swine. It offers antibiotic products including ALBAC, BMD, CHLORMAX and CHLORMAX-combination products, and AUREOMYCIN and AUREOMYCIN-combination products; anticoccidial comprising BIO-COX and CYGRO, BOVATEC and AVATEC, DECCOX, ROBENZ and CYCOSTAT, and ROFENAID; and antibacterial, including 3-NITRO and HISTOSTAT. The company also sells water soluble vitamins, minerals, and electrolytes that are used as nutritional supplements. The company was founded in 1975. It was formerly known as A.L. Laboratories, Inc. and changed its name to Alpharma, Inc. in 1994. Alpharma is headquartered in Bridgewater, New Jersey. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings